Phase II clinical study in patients with Parkinson's disease.
Phase 2
- Conditions
- Parkinson's disease
- Registration Number
- JPRN-jRCT2080221631
- Lead Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients diagnosed with Parkinson's disease in stages 1 to 4 on the modified Hoehn & Yahr scale
Exclusion Criteria
- Patients with a history of hypersensitivity to ropinirole
- Patients with clinically significant renal impairment or hepatic dysfunction
- Patients with skin disease at the application site for the investigational drug that may hinder its evaluation or patients receiving any treatment that may interfere with evaluation of the drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy, safety, and pharmacokinetics
- Secondary Outcome Measures
Name Time Method